Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.28 - $1.16 $167,244 - $692,869
597,301 Added 471.65%
723,942 $238,000
Q1 2024

May 01, 2024

BUY
$1.06 - $1.67 $134,239 - $211,490
126,641 New
126,641 $146,000
Q3 2023

Nov 13, 2023

BUY
$1.61 - $2.54 $112,233 - $177,063
69,710 New
69,710 $126,000
Q4 2021

Feb 11, 2022

SELL
$8.31 - $14.92 $354,861 - $637,128
-42,703 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$9.15 - $13.28 $390,732 - $567,095
42,703 New
42,703 $494,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.6B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.